Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway
Kristina Lindemann, Head of the Gynecological Oncology Center at Oslo University Hospital, shared a post on LinkedIn by ENGOT, adding:
“Thanks to the strong scientific community of ENGOT, we can offer a growing number of clinical trials to our patients with gynecological cancer, also in Norway.
Great to be part of this collaboration through our Nordic network NSGO-CTU.”
Quoting ENGOT‘s post:
“What makes an ENGOT trial unique? From start to finish, it’s about collaboration:
ENGOT brings together researchers from 21 groups across 33 countries to run clinical trials designed to address the most pressing challenges facing gynaecological oncology today. This collaborative model ensures our trials are scientifically rigorous and robust – and, above all, relevant to patients in Europe and beyond.
ENGOT, being a research network of the European Society of Gynaecological Oncology (ESGO) and alongside the European Network of Gynaecological Cancer Advocacy Groups (ESGO ENGAGe), we work together to ensure our research professionals and patients are supported, with engagement and equity, throughout the trial process.
Explore our website to learn more about our research groups, information about gynaecological cancers, ongoing clinical trials and more.”
More posts featuring Kristina Lindemann on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023